154 related articles for article (PubMed ID: 34200642)
1. LncRNA FENDRR Expression Correlates with Tumor Immunogenicity.
Munteanu MC; Sethuraman SN; Singh MP; Malayer J; Ranjan A
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200642
[TBL] [Abstract][Full Text] [Related]
2. The Therapeutic Value and Molecular Mechanisms of lncRNA FENDRR in Human Cancer.
Xu W; Wang B; Cai Y; Chen J; Meng E; Guo C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(39):4100-4106. PubMed ID: 34414867
[TBL] [Abstract][Full Text] [Related]
3. FENDRR: A pivotal, cancer-related, long non-coding RNA.
Zheng Q; Zhang Q; Yu X; He Y; Guo W
Biomed Pharmacother; 2021 May; 137():111390. PubMed ID: 33761608
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Role of LncRNA FENDRR in Multiple Cancers: A Review.
Fazaeli H; Sheikholeslami A; Ghasemian F; Amini E; Sheykhhasan M
Curr Mol Med; 2023 May; 23(7):606-629. PubMed ID: 35579154
[TBL] [Abstract][Full Text] [Related]
5. Fendrr involves in the pathogenesis of cardiac fibrosis via regulating miR-106b/SMAD3 axis.
Gong L; Zhu L; Yang T
Biochem Biophys Res Commun; 2020 Mar; 524(1):169-177. PubMed ID: 31982134
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis.
Zhang G; Wang Q; Zhang X; Ding Z; Liu R
Biomed Pharmacother; 2019 Oct; 118():109309. PubMed ID: 31545237
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer.
Pan H; Yu T; Sun L; Chai W; Liu X; Yan M
Transl Cancer Res; 2020 Jun; 9(6):3946-3959. PubMed ID: 35117761
[TBL] [Abstract][Full Text] [Related]
9. Lung-specific distant enhancer cis regulates expression of FOXF1 and lncRNA FENDRR.
Szafranski P; Gambin T; Karolak JA; Popek E; Stankiewicz P
Hum Mutat; 2021 Jun; 42(6):694-698. PubMed ID: 33739555
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA
Szafranski P; Stankiewicz P
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513839
[TBL] [Abstract][Full Text] [Related]
12. The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis.
Grote P; Herrmann BG
RNA Biol; 2013 Oct; 10(10):1579-85. PubMed ID: 24036695
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FENDRR Upregulation Promotes Hepatic Carcinoma Cells Apoptosis by Targeting miR-362-5p Via NPR3 and p38-MAPK Pathway.
Qian G; Jin X; Zhang L
Cancer Biother Radiopharm; 2020 Nov; 35(9):629-639. PubMed ID: 32251605
[No Abstract] [Full Text] [Related]
14. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.
Gong F; Dong D; Zhang T; Xu W
Eur J Pharmacol; 2019 Jun; 853():345-352. PubMed ID: 30981768
[TBL] [Abstract][Full Text] [Related]
15. The value of lncRNA
Herrera-Merchan A; Cuadros M; Rodriguez MI; Rodriguez S; Torres R; Estecio M; Coira IF; Loidi C; Saiz M; Carmona-Saez P; Medina PP
Oncotarget; 2020 Mar; 11(13):1172-1185. PubMed ID: 32284793
[TBL] [Abstract][Full Text] [Related]
16. A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
Yang L; Wu D; Chen J; Chen J; Qiu F; Li Y; Liu L; Cao Y; Yang B; Zhou Y; Lu J
Carcinogenesis; 2018 Mar; 39(3):347-359. PubMed ID: 29293945
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FENDRR attenuates colon cancer progression by repression of SOX4 protein.
Liu J; Du W
Onco Targets Ther; 2019; 12():4287-4295. PubMed ID: 31213846
[No Abstract] [Full Text] [Related]
18. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.
Qin X; Lu M; Zhou Y; Li G; Liu Z
Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519
[TBL] [Abstract][Full Text] [Related]
19. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.
Kun-Peng Z; Chun-Lin Z; Xiao-Long M
Int J Biol Sci; 2017; 13(9):1180-1191. PubMed ID: 29104509
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA FENDRR inhibits proliferation and invasion of hepatocellular carcinoma by down-regulating glypican-3 expression.
Wang B; Xian J; Zang J; Xiao L; Li Y; Sha M; Shen M
Biochem Biophys Res Commun; 2019 Jan; 509(1):143-147. PubMed ID: 30573358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
